ClinicalTrials.Veeva

Menu

PIO Laser Sclerectomy IOP SLT Sclerectomy (PIO laser SPNP)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Completed

Conditions

Primary Open-Angle Glaucoma

Treatments

Procedure: Selective Laser Trabeculoplasty (Tango Laser, Ellex)

Study type

Interventional

Funder types

Other

Identifiers

NCT01798732
2010-A00932-37 (Other Identifier)
1012

Details and patient eligibility

About

The main objective of this study is to characterize the changes in IOP over 24 hours after selective trabeculoplasty SLT (before and 1 and 6 months after treatment, decreased IOP, type of rhythm, mesor, acrophase, amplitude). The secondary objective is to evaluate changes in ocular perfusion pressure (arterial pressure - IOP) and ocular blood flow in the optic nerve head after selective laser trabeculoplasty.

Enrollment

26 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary Open-Angle Glaucoma
  • IOP more than 21 mmHg
  • Progression under maximal medical therapy
  • aged more than 18 years

Exclusion criteria

  • Pregnant woman

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

26 participants in 1 patient group

Selective laser trabeculoplasty (Tango Laser, Ellex)
Experimental group
Description:
Patients treated with selective laser trabeculoplasty (Tango Laser, Ellex, Minneapolis, USA)
Treatment:
Procedure: Selective Laser Trabeculoplasty (Tango Laser, Ellex)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems